Investing Profile

Jonathan Silverstein

Executive Partner at OrbiMed
orbimed.comNew York, New York
Photo of Jonathan Silverstein, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
OrbiMed Partner
$1M - $75.0M
CompanyStageDateRound SizeTotal Raised
Aspen Neuroscience
Series BMay 2022$150M
Series AApr 2020$70M
SeedDec 2019$7M
Co-investors: Peter Thompson (OrbiMed), Doug Fisher (InterWest), Sam Altman
AcureX Therapeutics
GrantAug 2021
Co-investors: Brian Fiske (Flagship Ventures)
Series UnknownAug 2020$33M
Series UnknownOct 2017$74M
Co-investors: James Blair (Domain Associates)
Prevail Therapeutics
Series BMar 2019$50M
Series AMar 2018$75M
Series ANov 2017$40M
Audentes Therapeutics
Series COct 2015$65M
Series BDec 2014$43M
Series AJul 2013$30M
Co-investors: Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Tom Woiwode (Versant Ventures), Jonathan Leff (Deerfield Management)
Series FFeb 2013$30M
Series EFeb 2011$30M
Series DAug 2008$35M
Co-investors: Paul Madera (Meritech Capital Partners), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest)
Series UnknownOct 2012$3M
Series CAug 2012$80M
Private EquityJul 2012$62M
Series BAug 2011$70M
Series BSep 2010$70M
Co-Founder The Silverstein Foundation for Parkinson's with GBA2017 - Present
Co-Head of Private Equity and General Partner OrbiMed Advisors1999 - Present
University of San Diego Doctor of Law (JD) and MBA
Denison University Bachelor's degree Economics